Filing Details

Accession Number:
0001042167-19-000006
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-01-23 17:38:27
Reporting Period:
2019-01-18
Accepted Time:
2019-01-23 17:38:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
863894 Veru Inc. VERU Pharmaceutical Preparations (2834) 391144397
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1276244 Shuster Mitchell Steiner 4400 Biscayne Boulevard, Suite 888
Miami FL 33137
President And Ceo Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-01-18 12,832 $1.34 7,751,935 No 4 S Direct
Common Stock Disposition 2019-01-23 12,768 $1.34 7,739,167 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 210,000 Indirect Footnote 4
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reported person on December 18, 2018.
  2. The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.33 to $1.35. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
  3. The price reported above is the weighted average transaction price. The range of prices for such transactions is $1.29 to $1.36. Upon request by the Commission staff, the reporting person will provide full information regarding the number of shares sold at each separate price.
  4. Shares are held by four individual trusts with each trust for the benefit of an adult child of the reporting person. The reporting person's brother is the trustee of each of the trusts. The reporting person disclaims beneficial ownership of these shares, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that the reporting person is the beneficial owner of these shares for purposes of Section 16 or any other purpose.